Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101672 publications

Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.

Sotorasib in non-small cell lung cancer KRAS G12C-mutated: from evidence to clinical practice.

Journal: Recenti progressi in medicina
Published: December 15, 2025

Corrigendum to "Pan-cancer analysis of IRF1 focusing on prognostic and immunological roles in non-small cell lung cancer" [Heliyon Volume 10, Issue 22, November 30 2024, Article e39861].

Corrigendum to "Pan-cancer analysis of IRF1 focusing on prognostic and immunological roles in non-small cell lung cancer" [Heliyon Volume 10, Issue 22, November 30 2024, Article e39861].

Journal: Heliyon
Published: December 15, 2025

Reply to comment on "Plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer".

Reply to comment on "Plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer".

Journal: Biomarkers in medicine
Published: December 15, 2025

Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison.

Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison.

Journal: Journal of comparative effectiveness research
Published: December 15, 2025

Commentary: Ultrasound Measurements of Skeletal Muscle Predict Chemotherapy Toxicity in Non-Small Cell Lung Cancer.

Commentary: Ultrasound Measurements of Skeletal Muscle Predict Chemotherapy Toxicity in Non-Small Cell Lung Cancer.

Journal: Nutrition and cancer
Published: December 15, 2025

Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.

Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.

Journal: American journal of clinical oncology
Published: December 15, 2025

Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score ≥50%: phase III study design.

Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score ≥50%: phase III study design.

Journal: Future oncology (London, England)
Published: December 13, 2025

Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P-glycoprotein.

Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with P-glycoprotein.

Journal: Future medicinal chemistry
Published: December 13, 2025

A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancer.

A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancer.

Journal: Future oncology (London, England)
Published: December 12, 2025

Correction to "Quantification of Diffuse Parenchymal Lung Disease in Non-Small Cell Lung Cancer Patients With Definitive Concurrent Chemoradiation Therapy for Predicting Radiation Pneumonitis".

Correction to "Quantification of Diffuse Parenchymal Lung Disease in Non-Small Cell Lung Cancer Patients With Definitive Concurrent Chemoradiation Therapy for Predicting Radiation Pneumonitis".

Journal: Thoracic cancer
Published: December 12, 2025

Unraveling the role of receptor-like protein tyrosine phosphatase PTPRH in cell signaling regulation and biological processes of non-small cell lung cancer.

Unraveling the role of receptor-like protein tyrosine phosphatase PTPRH in cell signaling regulation and biological processes of non-small cell lung cancer.

Journal: bioRxiv : the preprint server for biology
Published: December 12, 2025

Postoperative recurrence of ROS1-rearranged lung adenocarcinoma: A case series.

Postoperative recurrence of ROS1-rearranged lung adenocarcinoma: A case series.

Journal: The Thoracic and cardiovascular surgeon
Published: December 12, 2025
Showing 1-12 of 101,672

Last Updated: 01/07/2026